Hims & Hers Health, Inc. (HIMS)

US — Consumer Defensive Sector
Peers: ELF  NWL  GROV  EL  HNST  PG  COTY  NTCO  IPAR  CL  KVUE 

Automate Your Wheel Strategy on HIMS

With Tiblio's Option Bot, you can configure your own wheel strategy including HIMS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HIMS
  • Rev/Share 8.038
  • Book/Share 2.4743
  • PB 24.6821
  • Debt/Equity 0.1154
  • CurrentRatio 1.5942
  • ROIC 0.2452

 

  • MktCap 13157775780.0
  • FreeCF/Share 1.0821
  • PFCF 54.7745
  • PE 82.4653
  • Debt/Assets 0.0711
  • DivYield 0
  • ROE 0.3597

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Reiterated HIMS Needham -- Buy $61 $65 June 4, 2025
Downgrade HIMS TD Cowen Buy Hold -- $30 April 29, 2025
Downgrade HIMS Morgan Stanley Overweight Equal Weight $42 $60 Feb. 18, 2025
Downgrade HIMS Citigroup Neutral Sell $24 $25 Jan. 10, 2025
Initiation HIMS BTIG Research -- Buy -- $35 Jan. 7, 2025
Initiation HIMS Morgan Stanley -- Overweight -- $42 Dec. 17, 2024
Initiation HIMS Needham -- Buy -- $24 Aug. 22, 2024

News

Hims & Hers Health: Meme Potential Could Propel Explosive Growth
HIMS
Published: February 10, 2025 by: Seeking Alpha
Sentiment: Positive

Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Putting aside Hims meme potential, the company is still in a great position to disrupt the healthcare industry given its unique platform and business model. While Hims is building an increasingly innovative and high-quality business model, the company still faces major regulatory and competitive hurdles.

Read More
image for news Hims & Hers Health: Meme Potential Could Propel Explosive Growth
Hims & Hers stock price target according to the C&H pattern
HIMS
Published: February 10, 2025 by: Invezz
Sentiment: Positive

Hims & Hers stock price continues to fire on all cylinders this year and is hovering near its highest level on record. It has soared by almost 1,500% from its lowest level in 2023, transforming it into a leading juggernaut with a market cap of over $9.3 billion.

Read More
image for news Hims & Hers stock price target according to the C&H pattern

About Hims & Hers Health, Inc. (HIMS)

  • IPO Date 2019-09-13
  • Website https://www.forhims.com
  • Industry Household & Personal Products
  • CEO Mr. Andrew Dudum
  • Employees 1637

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.